Health Care & Life Sciences » Pharmaceuticals | IntelGenx Technologies Corp.

IntelGenx Technologies Corp. | Key People and Executives

Horst G. Zerbe
Chairman, President & Chief Executive Officer
Mark H. Nawacki
Director
Clemens Mayr
Director
John S. Marinucci
Independent Director
J. Bernard Boudreau
Vice Chairman
Bernd Josef Melchers
Independent Director
Horst G. Zerbe
Chairman, President & Chief Executive Officer
André Godin
CFO, Principal Accounting Officer & Executive VP
Nadine Paiement
Director-Research & Development
Dana Matzen
Vice President-Business Development
Mark H. Nawacki
Director
Clemens Mayr
Director
Stephen John Kilmer
Investor Relations Contact
Ingrid Zerbe
Secretary
John S. Marinucci
Independent Director
J. Bernard Boudreau
Vice Chairman
Bernd Josef Melchers
Independent Director

About IntelGenx Technologies

View Profile
Address
6420 Abrams
Ville Saint-Laurent Québec H4S 1X9
Canada
Employees -
Website http://www.intelgenx.com
Updated 07/08/2019
IntelGenx Technologies Corp. engages in the development of novel oral immediate-release and controlled-release products for the pharmaceutical market. Its products include rizaport, tadalafil, loxapine, and montelukast. It also offers a comprehensive portfolio of pharmaceutical services, such as pharmaceutical research and development, clinical monitoring, regulatory support, tech transfer and manufacturing scale-up, and commercial manufacturing.